Accession | Title | Series type(s) | Organism(s) | Samples | GDS | Supplementary | Contact | Release date |
---|---|---|---|---|---|---|---|---|
Filter | Expression profiling by high throughput sequencing | Jan 30, 2023 | ||||||
GSE216503 |
A next generation three-dimensional hydrogel-based culture system for studying host-pathogen interaction and drug efficacy in tuberculosis
|
|
11 | Rachit Agarwal | Jan 30, 2023 | |||
GSE221096 |
Activation of b-CATENIN in Fibro/Adipogenic Progenitors Leads to Muscle Mass Loss
|
|
11 | Fabio Rossi | Jan 30, 2023 | |||
GSE223677 |
Activation of tissue-resident NK and conventional NK are fundamentally different as indicated by their particular genesets
|
|
33 | Chao Zhong | Jan 30, 2023 | |||
GSE197392 |
ApoA-I nanotherapy rescues inadequate post-ischemic vascular adaptation in diabetic mice by modulating macrophage phenotype
|
|
50 | Tiit Örd | Jan 30, 2023 | |||
GSE217948 |
COVID-19 patient samples collected by the PREDICT-19 consortium
|
|
467 | Tracy Chew | Jan 30, 2023 | |||
GSE212243 |
Characterisation of the genetic mutation driving enhanced superantigen SpeA expression in Streptococcus pyogenes M1UK
|
|
41 | Magnus Ganer Jespersen | Jan 30, 2023 | |||
GSE212238 |
Characterisation of the genetic mutation driving enhanced superantigen SpeA expression in Streptococcus pyogenes M1UK (initial)
|
|
18 | Magnus Ganer Jespersen | Jan 30, 2023 | |||
GSE212239 |
Characterisation of the genetic mutation driving enhanced superantigen SpeA expression in Streptococcus pyogenes M1UK (second 5448)
|
|
5 | Magnus Ganer Jespersen | Jan 30, 2023 | |||
GSE212241 |
Characterisation of the genetic mutation driving enhanced superantigen SpeA expression in Streptococcus pyogenes M1UK (second SP1380)
|
|
9 | Magnus Ganer Jespersen | Jan 30, 2023 | |||
GSE212242 |
Characterisation of the genetic mutation driving enhanced superantigen SpeA expression in Streptococcus pyogenes M1UK (second SP1448)
|
|
9 | Magnus Ganer Jespersen | Jan 30, 2023 | |||
GSE184562 |
Chemical conversion of human conventional Pluripotent Stem Cells to Trophoblast Stem Cells following transient naive genes activation.
|
|
57 | Graziano Martello | Jan 30, 2023 | |||
GSE144555 |
DGAT1 is a bona fide oncogene stimulating cell growth and suppressing oxidative stress while enabling fatty acid accumulation
|
|
8 | Adam Hurlstone | Jan 30, 2023 | |||
GSE94236 |
Effect of systemic exposure of JAK1 Inhibition (AZ13748709) in C3H/HeJ Mice with Alopecia Areata In Vivo
|
|
24 | Elisabeth Israelsson | Jan 30, 2023 | |||
GSE208331 |
Effects of lactoferrin in PM2.5-induced nephrotoxicity
|
|
9 | Yung-Li Wang | Jan 30, 2023 | |||
GSE189669 |
Epigenetic reprogramming orchestrates transcriptional responses in shade avoidance syndrome of Arabidopsis
|
|
24 | Chuanwei Yang | Jan 30, 2023 | |||
GSE223539 |
Extracellular Nicotinamide Phosphoribosyltransferase neutralisation harnesses T cell responses in breast cancer by repressing the PD-1/PD-L1 axis
|
|
30 | Giorgia Colombo | Jan 30, 2023 | |||
GSE223545 |
Functionally and Metabolically Divergent Melanoma-Associated Macrophages Originate from Common Bone-Marrow Precursors
|
|
6 | Miller-Jensen Lab | Jan 30, 2023 | |||
GSE220294 |
Gene expression in untreated and TGF-b2-treated human bone marrow-derived mesenchymal stem cells
|
|
8 | Alix Kay Berglund | Jan 30, 2023 | |||
GSE69123 |
Genome-wide transcriptional alterations during vascular growth in skeletal muscles of type 2 diabetic mice in response to femoral artery ligation
|
|
24 | Minna U Kaikkonen | Jan 30, 2023 | |||
GSE212009 |
Heterogeneity of islet-infiltrating interleukin-21+ CD4 T cells in a mouse model of type 1 diabetes
|
|
2 | Yi-Guang Chen | Jan 30, 2023 |